For this update, we identified a new case statement which reported on a successful treatment of an individual with hemophilia B with inhibitors using ITI with rituximab, who reported the CD20\positive lymphocyte count was a useful marker to guide ITI therapy (Kobayashi 2015)
For this update, we identified a new case statement which reported on a successful treatment of an individual with hemophilia B with inhibitors using ITI with rituximab, who reported the CD20\positive lymphocyte count was a useful marker to guide ITI therapy (Kobayashi 2015). Regarding safety issues, rituximab\related adverse reactions have been reported to include the…